Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular testing for endometrial cancer: An SGO clinical practice statement
Christine Walsh, Kari Hacker, Angeles Alvarez Secord, et al.
Gynecologic Oncology (2022) Vol. 168, pp. 48-55
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

The Histomorphology to Molecular Transition: Exploring the Genomic Landscape of Poorly Differentiated Epithelial Endometrial Cancers
Thulo Molefi, Lloyd Mabonga, Rodney Hull, et al.
Cells (2025) Vol. 14, Iss. 5, pp. 382-382
Open Access | Times Cited: 1
Race, Prevalence of POLE and POLD1 Alterations, and Survival Among Patients With Endometrial Cancer
Shuhua Zheng, Eric D. Donnelly, Jonathan Strauss
JAMA Network Open (2024) Vol. 7, Iss. 1, pp. e2351906-e2351906
Open Access | Times Cited: 5
Novel Molecular Targets in Endometrial Cancer: Mechanisms and Perspectives for Therapy
Pamela Soberanis Pina, Stéphanie Lheureux
Biologics (2024) Vol. Volume 18, pp. 79-93
Open Access | Times Cited: 4
Updates and Controversies in the Management of Uterine Serous Carcinoma and Uterine Carcinosarcoma
Michael D. Toboni, Katherine C. Kurnit, Britt Erickson, et al.
International Journal of Gynecological Cancer (2025) Vol. 35, Iss. 3, pp. 101672-101672
Closed Access
HER2 amplification and HER2 low expression in endometrial carcinoma: prevalence across molecular, histological and clinicopathological risk groups
Karoliina Aro, Mikko Loukovaara, Ralf Bützow, et al.
BJC Reports (2025) Vol. 3, Iss. 1
Open Access
HER2 expression in a molecularly defined cohort of endometrial cancer patients: The SPECTRUM study
Alfonso Cortés-Salgado, Esther Moreno-Moreno, Irene Carretero‐Barrio, et al.
Gynecologic Oncology (2025) Vol. 194, pp. 33-40
Open Access
Endometrial cancer somatic testing practice patterns among gynecologic oncologists
Joseph DeMari, Deanna Glassman, S. Smith, et al.
Gynecologic Oncology (2025) Vol. 195, pp. 149-151
Closed Access
Present progress in biomarker discovery of endometrial cancer by multi-omics approaches
Yuhao An, Quanxin Feng, Jia Li, et al.
Clinical Proteomics (2025) Vol. 22, Iss. 1
Open Access
Training, Validating, and Testing Machine Learning Prediction Models for Endometrial Cancer Recurrence
Jesús González Bosquet, Andrew Polio, Erin George, et al.
JCO Precision Oncology (2025), Iss. 9
Closed Access
Deficient Mismatch Repair and Microsatellite Instability in Solid Tumors
Joy Awosika, James L. Gulley, Danielle M. Pastor
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4394-4394
Open Access
Rare Uterine Tumors: What to Do?
Erin K. Crane, Stéphanie Gaillard, Martee L. Hensley
American Society of Clinical Oncology Educational Book (2025) Vol. 45, Iss. 3
Closed Access
Adoption of Universal Testing in Endometrial Cancers for Microsatellite Instability Using Next-Generation Sequencing
Isabel V. Rodriguez, Sarah Strickland, David N. Wells, et al.
JCO Precision Oncology (2023), Iss. 7
Closed Access | Times Cited: 7
Differences in single gene expression patterns and signaling pathways between Black and White patients in high grade endometrioid endometrial cancer independent of BMI
Janina V. Pearce, Caitlin Durr, Xufeng Qu, et al.
Gynecologic Oncology Reports (2024) Vol. 52, pp. 101360-101360
Open Access | Times Cited: 1
Analysis of Prognostic Factors and Cancer-Specific Survival in Patients with Undifferentiated and Dedifferentiated Endometrial Carcinoma Undergoing Various Postoperative Adjuvant Therapies
Youren Dai, Huiyun Wu, Jiahui Cao, et al.
Cancer Management and Research (2024) Vol. Volume 16, pp. 559-573
Open Access | Times Cited: 1
Ferroptosis: a promising target for fumarate hydratase-deficient tumor therapeutics literature review
Ping Cheng, Ruohan Xia, Xianwang Wang
Translational Cancer Research (2024) Vol. 13, Iss. 6, pp. 3126-3141
Open Access | Times Cited: 1
Predictive biomarkers in endometrial carcinomas: a review of their relevance in daily anatomic pathology
Janaína Nagel, Rafael Bispo Paschoalini, Patrícia Barreto, et al.
Surgical and Experimental Pathology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 1
Immune signatures of the POLE mutation in endometrial carcinomas: a systematic study based on TCGA data and clinical cohort validation
Tieyan Wang, Dan Yu, Juanjuan Wang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
The Development Process of Endometrial Cancer from Tissue to Molecular Typing
筱茹 侯
Advances in Clinical Medicine (2024) Vol. 14, Iss. 04, pp. 356-363
Closed Access
CD73 restrains mutant β-catenin oncogenic activity in endometrial carcinomas
Rebecca M. Hirsch, Sunthoshini Premsankar, Katherine C. Kurnit, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
The advent of immune checkpoint inhibition for the treatment of patients with primary advanced or recurrent dMMR/MSI high endometrial cancer in 2025
Tarik Silk, Kari Hacker, Whitfield B. Growdon, et al.
Current Opinion in Obstetrics & Gynecology (2024)
Closed Access
Phosphocholine inhibits proliferation and reduces stemness of endometrial cancer cells by downregulating mTOR-c-Myc signaling
Kunxiang Gong, Yanqin Zheng, Yaqiong Liu, et al.
Cellular and Molecular Life Sciences (2024) Vol. 82, Iss. 1
Open Access
Improvement of Diagnosis by Transvaginal Ultrasound and Prognosis of Endometrial Cancer using miR-222-3p: A Prospective Cohort Study
Sizhou Feng, Yinping Huang, Juan Liao, et al.
Clinical and Experimental Obstetrics & Gynecology (2024) Vol. 51, Iss. 12
Open Access
The Multi‐Kinase Inhibitor GZD824 (Olverembatinib) Shows Pre‐Clinical Efficacy in Endometrial Cancer
Dongli Liu, Dylan M. Glubb, Tracy A. O’Mara, et al.
Cancer Medicine (2024) Vol. 14, Iss. 1
Open Access
Utility of SOX10 and estrogen receptor immunohistochemical expression in endometrial carcinoma of Egyptian patients
Mona A. Kora, Alyaa A. Moselhy, Rania Abdallah Abdallah
Egyptian Journal of Pathology (2024) Vol. 44, Iss. 2, pp. 190-199
Closed Access
Look at This Swelling: Retroauricular Mass as Atypical Progression in Long-Survivor Endometrial Endometrioid Adenocarcinoma
Marco De Felice, Elena Tammaro, Mariagrazia Tammaro, et al.
Cureus (2023)
Open Access
Page 1 - Next Page

Scroll to top